Dr. Sunir Joshi, MD

Dr. Joshi practices at South Florida Vision Associates in Fort Lauderdale, Florida.

Dr. Joshi's NPI, 1659564862, was assigned on August 21, 2007. Dr. Joshi graduated from Drexel University College Of Medicine in 2006. Dr. Joshi holds Florida license ME102941.

Dr. Joshi's primary practice is South Florida Vision Associates, at 2900 W Cypress Creek Rd, Fort Lauderdale, FL 33309 in Broward County. The practice phone is (904) 456-3946.

Dr. Joshi's primary practice is South Florida Vision Associates in Fort Lauderdale, Florida. Dmand AI also links Dr. Joshi to 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Joshi practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Joshi's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Joshi is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Joshi's licenses on file in 2 states: Florida and Georgia.

Dmand AI lists age-related macular degeneration and inflammation of iris among the conditions Dr. Joshi treats.

CMS data shows 1,853 Medicare services from Dr. Joshi across 8 procedure codes in 2024, for 141 Medicare patients. Medicare paid $69,289 for them. Every service was in an office.

CMS counts 141 Medicare patients who saw Dr. Joshi in 2024. The largest group is 65 to 74, with 62 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 16% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Joshi's median patient age at 73, with 61% women.

In 2024, Dr. Joshi wrote 428 Medicare Part D claims for 118 patients. 40% of them were for generic drugs. CMS names the drug for 387 of them, across 12 drugs with 11 or more claims each, at $49,770 in total drug cost. In 2023, CMS named 2,025 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Joshi for performance year 2024, reported through an alternative payment model (APM). Dr. Joshi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 6 papers to Dr. Joshi, published from 2011 to 2024. 2020 was the busiest year, with 2. The most frequent topics are Angiogenesis Inhibitors, Diabetes Mellitus and Diabetic Retinopathy. Dr. Joshi's most frequent co-authors are Robert David Gross, MBA, MD, Michael B. Raizman, MD and Bruce A. Segal, MD.

Dmand AI links Dr. Joshi to 3 clinical trials. Conditions studied include Conjunctivitis, Bacterial, Macular Degeneration and Eye Infections, Bacterial. Shire sponsors the most, 2. Open Payments lists research payments to Dr. Joshi that name 3 trials.

CMS Open Payments shows 237 general payments to Dr. Joshi from 24 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 52% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $13,823. It also lists 29 research payments totaling $911,913 from 2018 to 2025, naming 3 clinical trials.

Dr. Joshi graduated from Drexel University College Of Medicine in 2006.

Dr. Joshi is in network with 20 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.